Francis M. Filloux
( out of 24 reviews )

Francis M. Filloux, MD

Languages spoken: Spanish, French, English

Clinical Locations

Primary Location

Eccles Primary Children's Outpatient Services

81 N Mario Capecchi Drive
Salt Lake City , UT 84113
801-213-3599
Get Directions

Primary Children's Hospital Outpatient Services at Riverton

3773 West 12600 South
Riverton , UT 84065
801-213-3599
Get Directions

Dr. Francis Filloux is a Professor in the Pediatric Neurology Division at the University of Utah and Primary Children’s Hospital in Salt Lake City.

He is a general child neurologist who sees children with all forms of neurological disease, having special interest in tic disorders, Tourette's, and neurobehavioral problems.

Specialties

Board Certification

National Board of Medical Examiners
American Board of Psychiatry & Neurology (Special Qualification in Child Neurology)
American Board of Pediatrics (Pediatrics)

Patient Rating

5.0 /5
( out of 24 reviews )

The patient rating score is an average of all responses on our patient experience survey. The rating averages scores for all questions about care from our providers. The scale on which responses are measured is 1 to 5 with 5 being the best score.

Dr. Francis Filloux is a Professor in the Pediatric Neurology Division at the University of Utah and Primary Children’s Hospital in Salt Lake City.

He is a general child neurologist who sees children with all forms of neurological disease, having special interest in tic disorders, Tourette's, and neurobehavioral problems.

Board Certification and Academic Information

Academic Departments Pediatrics -Professor
Neurology -Professor
Academic Divisions Neurology
Board Certification
National Board of Medical Examiners
American Board of Psychiatry & Neurology (Special Qualification in Child Neurology)
American Board of Pediatrics (Pediatrics)

Education history

Undergraduate Anthropology - University of California at San Diego B.A.
Professional Medical Medicine - University of California - Los Angeles M.D.
Internship Pediatrics - University of Utah School of Medicine Intern
Residency Pediatrics - University of Utah School of Medicine Resident
Residency Pediatric Neurology - University of Utah School of Medicine Resident
Chief Resident Pediatric Neurology - University of Utah School of Medicine Chief Resident
Fellowship Neuropharmacology - University of Utah School of Medicine Fellow
Post Graduate Training David Eccles School of Business, Leadership Development for Physician Executives. University of Utah Certificate
Post Graduate Training Leadership Development Program for Faculty and Director Staff, University of Utah
Certification Mini-Advanced Training Program in Health Care Delivery Improvement - Intermountain Institute for Health Care Delivery Research Certification

Selected Publications

Journal Article

  1. Keeney KI, Filloux F (2024). Suppporting Autonomy for Patients with Intellectual Disabilities: Principles for Care Providers. Journal of Pediatric Neurology and Neuroscience, 8(1), 252-259.
  2. Langford J, Vukadin L, Carey JC, Botto LD, Velinder M, Mao R, Miller CE, Filloux F, Ahn E (2023). SON-Related Zhu-Tokita-Takenouchi-Kim Syndrome With Recurrent Hemiplegic Migraine: Putative Role of PRRT2. Neurology. Genetics, 9(3), e200062.
  3. Mattison KA, Tossing G, Mulroe F, Simmons C, Butler KM, Schreiber A, Alsadah A, Neilson DE, Naess K, Wedell A, Wredenberg A, Sorlin A, McCann E, Burghel GJ, Menendez B, Hoganson GE, Botto LD, Filloux FM, Aledo-Serrano Á, Gil-Nagel A, Tatton-Brown K, Verbeek NE, van der Zwaag B, Aleck KA, Fazenbaker AC, Balciuniene J, Dubbs HA, Marsh ED, Garber K, Ek J, Duno M, Hoei-Hansen CE, Deardorff MA, Raca G, Quindipan C, van Hirtum-Das M, Breckpot J, Hammer TB, Møller RS, Whitney A, Douglas AGL, Kharbanda M, Brunetti-Pierri N, Morleo M, Nigro V, May HJ, Tao JX, Argilli E, Sherr EH, Dobyns WB, Genomics England Research Consortium, Baines RA, Warwicker J, Parker JA, Banka S, Campeau PM, Escayg (2023). ATP6V0C variants impair V-ATPase function causing a neurodevelopmental disorder often associated with epilepsy. Brain, 146(4), 1357-1372.
  4. Thiele EA, Bebin EM, Filloux F, Kwan P, Loftus R, Sahebkar F, Sparagana S, Wheless (2022). Long-term cannabidiol treatment for seizures in patients with tuberous sclerosis complex: An open-label extension trial. Epilepsia, 63(2), 426-439.
  5. McLean H, Palmquist R, Nadauld LD, Malone Jenkins S, Bonkowsky J, Filloux (2022). On the edge-A diagnostic odyssey. Clinical case reports, 10(4), e05688.
  6. McKnight D, Morales A, Hatchell KE, Bristow SL, Bonkowsky JL, Perry MS, Berg AT, Borlot F, Esplin ED, Moretz C, Angione K, Ríos-Pohl L, Nussbaum RL, Aradhya S, ELEVIATE Consortium, Haldeman-Englert CR, Levy RJ, Parachuri VG, Lay-Son G, de Montellano DJD, Ramirez-Garcia MA, Benítez Alonso EO, Ziobro J, Chirita-Emandi A, Felix TM, Kulasa-Luke D, Megarbane A, Karkare S, Chagnon SL, Humberson JB, Assaf MJ, Silva S, Zarroli K, Boyarchuk O, Nelson GR, Palmquist R, Hammond KC, Hwang ST, Boutlier SB, Nolan M, Batley KY, Chavda D, Reyes-Silva CA, Miroshnikov O, Zuccarelli B, Amlie-Wolf L, Wheless JW, Seinfeld S, Kanhangad M, Freeman JL, Monroy-Santoyo S, Rodriguez-Vazquez N, Ryan MM, Machie M, Guerra P, Hassan MJ, Candee MS, Bupp CP, Park KL, Muller E 2nd, Lupo P, Pedersen RC, Arain AM, Murphy A, Schatz K, Mu W, Kalika PM, Plaza L, Kellogg MA, Lora EG, Carson RP, Svystilnyk V, Venegas V, Luke RR, Jiang H, Stetsenko T, Dueñas-Roque MM, Trasmonte J, Burke RJ, Hurst ACE, Smith DM, Massingham LJ, Pisani L, Costin CE, Ostrander B, Filloux FM, Ananth AL, Mohamed IS, Nechai A, Dao JM, Fahey MC, Aliu E, Falchek S, Press CA, Treat L, Eschbach K, Starks A, Kammeyer R, Bear JJ, Jacobson M, Chernuha V, Meibos B, Wong K, Sweney MT, Espinoza AC, Van Orman CB, Weinstock A, Kumar A, Soler-Alfonso C, Nolan DA, Raza M, Rojas Carrion MD, Chari G, Marsh ED, Shiloh-Malawsky Y, Parikh S, Gonzalez-Giraldo E, Fulton S, Sogawa Y, Burns K, Malets M, Montiel Blanco JD, Habela CW, Wilson CA, Guzmán GG, Pavliuk (2022). Genetic Testing to Inform Epilepsy Treatment Management From an International Study of Clinical Practice. JAMA neurology, 79(12), 1267-1276.
  7. Thiele EA, Bebin EM, Bhathal H, Jansen FE, Kotulska K, Lawson JA, O'Callaghan FJ, Wong M, Sahebkar F, Checketts D, Knappertz V, GWPCARE6 Study Group (2021). Add-on Cannabidiol Treatment for Drug-Resistant Seizures in Tuberous Sclerosis Complex: A Placebo-Controlled Randomized Clinical Trial. JAMA neurology, 78(3), 285-292.
  8. Borlot F, de Almeida BI, Combe SL, Andrade DM, Filloux FM, Myers KA (2019). Clinical utility of multigene panel testing in adults with epilepsy and intellectual disability. Epilepsia, 60(8), 1661-1669.
  9. Gregerson CHY, Bakian AV, Wilkes J, Knighton AJ, Nkoy F, Sweney M, Filloux FM, Bonkowsky JL (2019). Disparities in Pediatric Epilepsy Remission Are Associated With Race and Ethnicity. J Child Neurol, 34(14), 928-936.
  10. Clark EB, Butterfield RJ, Filloux FM, Bonkowsky J (2019). Development, Implementation, and Use of a Neurology Therapeutics Committee. Child neurology open, 6, 2329048X19830473.
  11. Borlot F, de Almeida BI, Combe SL, Andrade DM, Filloux FM, Myers K (2019). Clinical utility of multigene panel testing in adults with epilepsy and intellectual disability. Epilepsia, 60(8), 1661-1669.
  12. Helbig KL, Lauerer RJ, Bahr JC, Souza IA, Myers CT, Uysal B, Schwarz N, Gandini MA, Huang S, Keren B, Mignot C, Afenjar A, Billette de Villemeur T, H�ron D, Nava C, Valence S, Buratti J, Fagerberg CR, Soerensen KP, Kibaek M, Kamsteeg EJ, Koolen DA, Gunning B, Schelhaas HJ, Kruer MC, Fox J, Bakhtiari S, Jarrar R, Padilla-Lopez S, Lindstrom K, Jin SC, Zeng X, Bilguvar K, Papavasileiou A, Xing Q, Zhu C, Boysen K, Vairo F, Lanpher BC, Klee EW, Tillema JM, Payne ET, Cousin MA, Kruisselbrink TM, Wick MJ, Baker J, Haan E, Smith N, Sadeghpour A, Davis EE, Katsanis N, Task Force for Neonatal Genomics., Corbett MA, MacLennan AH, Gecz J, Biskup S, Goldmann E, Rodan LH, Kichula E, Segal E, Jackson KE, Asamoah A, Dimmock D, McCarrier J, Botto LD, Filloux F, Tvrdik T, Cascino GD, Klingerman S, Neumann C, Wang R, Jacobsen JC, Nolan MA, Snell RG, Lehnert K, Sadleir LG, Anderlid BM, Kvarnung M, Guerrini R, Friez MJ, Lyons MJ, Leonhard J, Kringlen G, Casas K, El Achkar CM, Smith LA, Rotenberg A, Poduri A, Sanchis-Juan A, Carss KJ, Rankin J, Zeman A, Raymond FL, Blyth M, Kerr B, Ruiz K, Urquhart J, Hughes I, Banka S, Deciphering Developmental Disorders Study., Hedrich UBS, Scheffer IE, Helbig I, Zamponi GW, Lerche H, Mefford HC (2018). De Novo Pathogenic Variants in CACNA1E Cause Developmental and Epileptic Encephalopathy with Contractures, Macrocephaly, and Dyskinesias. Am J Hum Genet, 103(5), 666-678.
  13. Devinsky O, Verducci C, Thiele EA, Laux LC, Patel AD, Filloux F, Szaflarski JP, Wilfong A, Clark GD, Park YD, Seltzer LE, Bebin EM, Flamini R, Wechsler RT, Friedman D (2018). Open-label use of highly purified CBD (Epidiolex(R)) in patients with CDKL5 deficiency disorder and Aicardi, Dup15q, and Doose syndromes. Epilepsy Behav, 86, 131-137.
  14. Ostrander BEP, Butterfield RJ, Pedersen BS, Farrell AJ, Layer RM, Ward A, Miller C, DiSera T, Filloux FM, Candee MS, Newcomb T, Bonkowsky JL, Marth GT, Quinlan AR (2018). Whole-genome analysis for effective clinical diagnosis and gene discovery in early infantile epileptic encephalopathy. NPJ Genom Med, 3, 22.
  15. Devinsky O, Cross JH, Laux L, Marsh E, Miller I, Nabbout R, Scheffer IE, Thiele EA, Wright S, Cannabidiol in Dravet Syndrome Study Group. (2017). Trial of Cannabidiol for Drug-Resistant Seizures in the Dravet Syndrome. N Engl J Med, 376(21), 2011-2020.
  16. Ward A, Karren MA, Di Sera T, Miller C, Velinder M, Qiao Y, Filloux FM, Ostrander B, Butterfield R, Bonkowsky JL, Dere W, Marth GT (2017). Rapid clinical diagnostic variant investigation of genomic patient sequencing data with iobio web tools. J Clin Transl Sci, 1(6), 381-386.
  17. Byrne S, Jansen L, U-King-Im JM, Siddiqui A, Lidov HG, Bodi I, Smith L, Mein R, Cullup T, Dionisi-Vici C, Al-Gazali L, Al-Owain M, Bruwer Z, Al Thihli K, El-Garhy R, Flanigan KM, Manickam K, Zmuda E, Banks W, Gershoni-Baruch R, Mandel H, Dagan E, Raas-Rothschild A, Barash H, Filloux F, Creel D, Harris M, Hamosh A, K�lker S, Ebrahimi-Fakhari D, Hoffmann GF, Manchester D, Boyer PJ, Manzur AY, Lourenco CM, Pilz DT, Kamath A, Prabhakar P, Rao VK, Rogers RC, Ryan MM, Brown NJ, McLean CA, Said E, Schara U, Stein A, Sewry C, Travan L, Wijburg FA, Zenker M, Mohammed S, Fanto M, Gautel M, Jungbluth H (2016). EPG5-related Vici syndrome: a paradigm of neurodevelopmental disorders with defective autophagy. Brain, 139(Pt 3), 765-81.
  18. Roundy LM, Filloux FM, Kerr L, Rimer A, Bonkowsky JL (2016). Seizure Action Plans Do Not Reduce Health Care Utilization in Pediatric Epilepsy Patients. J Child Neurol, 31(4), 433-8.
  19. Nelson GR, Filloux FM, Kerr LM (2016). Educational Intervention Improves Compliance With AAN Guidelines for Return Epilepsy Visits: A Quality Improvement Project. J Child Neurol, 31(11), 1320-3.
  20. Devinsky O, Marsh E, Friedman D, Thiele E, Laux L, Sullivan J, Miller I, Flamini R, Wilfong A, Filloux F, Wong M, Tilton N, Bruno P, Bluvstein J, Hedlund J, Kamens R, Maclean J, Nangia S, Singhal NS, Wilson CA, Patel A, Cilio MR (2016). Cannabidiol in patients with treatment-resistant epilepsy: an open-label interventional trial. Lancet Neurol, 15(3), 270-8.
  21. Filloux FM (2015). Cannabinoids for pediatric epilepsy? Up in smoke or real science? Transl Pediatr, 4(4), 271-82.
  22. Filloux FM, Hoffman RO, Viskochil DH, Jungbluth H, Creel DJ (2014). Ophthalmologic features of Vici syndrome. J Pediatr Ophthalmol Strabismus, 51(4), 214-20.
  23. Cullup T, Kho AL, Dionisi-Vici C, Brandmeier B, Smith F, Urry Z, Simpson MA, Yau S, Bertini E, McClelland V, Al-Owain M, Koelker S, Koerner C, Hoffmann GF, Wijburg FA, ten Hoedt AE, Rogers RC, Manchester D, Miyata R, Hayashi M, Said E, Soler D, Kroisel PM, Windpassinger C, Filloux FM, Al-Kaabi S, Hertecant J, Del Campo M, Buk S, Bodi I, Goebel HH, Sewry CA, Abbs S, Mohammed S, Josifova D, Gautel M, Jungbluth H (2013). Recessive mutations in EPG5 cause Vici syndrome, a multisystem disorder with defective autophagy. Nat Genet, 45(1), 83-7.
  24. Stockmann C, Ampofo K, Byington CL, Filloux F, Hersh AL, Blaschke AJ, Cowan P, Korgenski K, Mason EO, Pavia AT (2013). Pneumococcal meningitis in children: epidemiology, serotypes, and outcomes from 1997-2010 in Utah. Pediatrics, 132(3), 421-8.
  25. Candee MS, Carey JC, Krantz ID, Filloux FM (2012). Seizure characteristics in Pallister-Killian syndrome. Am J Med Genet A, 158A(12), 3026-32.
  26. Filloux FM, Carey JC, Krantz ID, Ekstrand JJ, Candee MS (2012). Occurrence and clinical features of epileptic and non-epileptic paroxysmal events in five children with Pallister-Killian syndrome. Eur J Med Genet, 55(5), 367-73.
  27. Bonkowsky JL, Nelson C, Kingston JL, Filloux FM, Mundorff MB, Srivastava R. (2010). The Burden of Inherited Leukodystrophies in Children. Neurology, 75(8), 718-725.
  28. Holsti M, Dudley N, Schunk J, Adelgais K, Greenberg R, Olsen C, Healy A, Firth S, Filloux F (2010). Intranasal midazolam vs rectal diazepam for the home treatment of acute seizures in pediatric patients with epilepsy. Arch Pediatr Adolesc Med, 164(8), 747-53.
  29. Bonkowsky JL, Nelson C, Kingston JL, Filloux FM, Mundorff MB, Srivastava (2010). The burden of inherited leukodystrophies in children. Neurology, 75(8), 718-25.
  30. Bonkowsky JL, Guenther E, Srivastava R, Filloux FM (2009). Seizures in children following an apparent life-threatening event. J Child Neurol, 24(6), 709-13.
  31. Singh NA, Pappas C, Dahle EJ, Claes LR, Pruess TH, De Jonghe P, Thompson J,Dixon M, Gurnett C, Peiffer A, White HS, Filloux F, Leppert MF (2009). A role of SCN9A in human epilepsies, as a cause of febrile seizures and as a potential modifier of Dravet syndrome. PLoS Genet, 5(9), e1000649.
  32. Bonkowsky JL, Guenther E, Filloux FM, Srivastava R (2008). Death, child abuse, and adverse neurological outcome of infants after an apparent life-threatening event. Pediatrics, 122(1), 125-31.
  33. Bonkowsky JL, Filloux FM, Warner JE (2007). Splenial corpus callosum lesion and hemifield visual color anomia associated with intracranial hypertension. J Child Neurol, 22(9), 1132-4.
  34. Holsti M, Sill BL, Firth SD, Filloux FM, Joyce SM, Furnival RA (2007). Prehospital intranasal midazolam for the treatment of pediatric seizures. Pediatr Emerg Care, 23(3), 148-53.
  35. Caplin DA, Rao JK, Filloux F, Bale JF, Van Orman C (2006). Development of performance indicators for the primary care management of pediatric epilepsy: expert consensus recommendations based on the available evidence. Epilepsia, 47(12), 2011-9.
  36. Henderson CB, Filloux FM, Alder SC, Lyon JL, Caplin DA (2006). Efficacy of the ketogenic diet as a treatment option for epilepsy: meta-analysis. J Child Neurol, 21(3), 193-8.
  37. Bonkowsky JL, Filloux FM, Byington CL (2006). Herpes simplex virus central nervous system relapse during treatment of infantile spasms with corticotropin. Pediatrics, 117(5), e1045-8.
  38. Thompson JA, Filloux FM, Van Orman CB, Swoboda K, Peterson P, Firth SD, Bale JF Jr (2005). Infant botulism in the age of botulism immune globulin. Neurology, 64(12), 2029-32.
  39. Benedict SL, Bonkowsky JL, Thompson JA, Van Orman CB, Boyer RS, Bale JF Jr, Filloux FM (2004). Cerebral sinovenous thrombosis in children: another reason to treat iron deficiency anemia. J Child Neurol, 19(7), 526-31.
  40. Singh NA, Westenskow P, Charlier C, Pappas C, Leslie J, Dillon J, The BFNC Physician Consortium (Filloux FM, et al) Leppert MF (2003). KCNQ2 and KCNQ3 Potassium Channel Genes in Benign Familial Neonatal Convulsions: Expansion of the functional and Mutation Spectrum. Brain, 126, 2726-2737.
  41. Cannon G, Caravati EM, Filloux F (2003). Hydrogen Peroxide Neurotoxicity in Childhood: Case Report with Unique MRI Features. J Child Neurol, 18, 805-8.
  42. Bonkowsky J, Filloux F (2003). Extrapontine Myelinolysis in a Pediatric Case of Diabetic Ketoacidosis. J Child Neurol, 18, 144-7.
  43. McMahon WM, Filloux FM, Ashworth JC, Jensen J (2002). Movement disorders in children and adolescents. Neurol Clin, 20(4), 1101-24, vii-viii.
  44. Albensi BC, Schweizer MP, Rarick TM, Filloux F (1999). Unilateral hypoxic-ischemic injury in the neonatal rat brain evaluated by in vivo MRI. Correlation with histopathology and neuroprotection by MK-801. Invest Radiol, 34(4), 249-61.
  45. Albensi BC, Schweizer MP, Rarick TM, Filloux F (1998). Magnetic resonance imaging of hypoxic-ischemic brain injury in the neonatal rat. Invest Radiol, 33(7), 377-85.
  46. Ozonoff S, Strayer DL, McMahon WM, Filloux F (1998). Inhibitory deficits in Tourette syndrome: a function of comorbidity and symptom severity. J Child Psychol Psychiatry, 39(8), 1109-18.
  47. Filloux FM, Adair J, Narang N (1996). The temporal evolution of striatal dopamine receptor binding and mRNA expression following hypoxia-ischemia in the neonatal rat. Brain Res Dev Brain Res, 94(1), 81-91.
  48. McMahon WM, van de Wetering BJ, Filloux F, Betit K, Coon H, Leppert M (1996). Bilineal transmission and phenotypic variation of Tourette's disorder in a large pedigree. J Am Acad Child Adolesc Psychiatry, 35(5), 672-80.
  49. Filloux FM (1996). Neuropathophysiology of movement disorders in cerebral palsy. J Child Neurol, 11 Suppl 1, S5-12.
  50. Hasstedt SJ, Leppert M, Filloux F, van de Wetering BJ, McMahon WM (1995). Intermediate inheritance of Tourette syndrome, assuming assortative mating. Am J Hum Genet, 57(3), 682-9.
  51. Johnson M, Hanson GR, Gibb JW, Adair J, Filloux F (1994). Effect of neonatal hypoxia-ischemia on nigro-striatal dopamine receptors and on striatal neuropeptide Y, dynorphin A and substance P concentrations in rats. Brain Res Dev Brain Res, 83(1), 109-18.
  52. Filloux F, Schapper A, Naisbitt SR, Olivera BM, McIntosh JM (1994). Complex patterns of [125I]omega-conotoxin GVIA binding site expression during postnatal rat brain development. Brain Res Dev Brain Res, 78(1), 131-6.
  53. Filloux FM, Fitts RC, Skeen GA, White HS (1994). The dihydropyridine nitrendipine inhibits [3H]MK 801 binding to mouse brain sections. Eur J Pharmacol, 269(3), 325-30.
  54. Ozonoff S, Strayer DL, McMahon WM, Filloux F (1994). Executive function abilities in autism and Tourette syndrome: an information processing approach. J Child Psychol Psychiatry, 35(6), 1015-32.
  55. Merchant KM, Dobie DJ, Filloux FM, Totzke M, Aravagiri M, Dorsa DM (1994). Effects of chronic haloperidol and clozapine treatment on neurotensin and c-fos mRNA in rat neostriatal subregions. J Pharmacol Exp Ther, 271(1), 460-71.
  56. Filloux F, Karras J, Imperial JS, Gray WR, Olivera BM (1994). The distribution of omega-conotoxin MVIICnle-binding sites in rat brain measured by autoradiography. Neurosci Lett, 178(2), 263-6.
  57. Filloux F, Townsend JJ (1993). Pre- and postsynaptic neurotoxic effects of dopamine demonstrated by intrastriatal injection. Exp Neurol, 119(1), 79-88.
  58. McIntosh JM, Adams ME, Olivera BM, Filloux F (1992). Autoradiographic localization of the binding of calcium channel antagonist, [125I]omega-agatoxin IIIA, in rat brain. Brain Res, 594(1), 109-14.
  59. Adair J, Filloux F (1992). Effects of hypoxic-ischemic brain damage on dopaminergic markers in the neonatal rat: a regional autoradiographic analysis. J Child Neurol, 7(2), 199-207.
  60. Kerr L, Filloux FM (1992). Cerebral infarction as a remote complication of childhood Haemophilus influenzae meningitis. West J Med, 157(2), 179-82.
  61. Filloux F, Richards TJ, Huff GF, Wamsley JK (1991). Quinolinic acid lesion of nucleus accumbens reduces D1 but not D2 dopamine receptors: an autoradiographic study. Life Sci, 48(26), 2535-42.
  62. Filloux F, Wamsley JK (1991). Dopaminergic modulation of excitotoxicity in rat striatum: evidence from nigrostriatal lesions. Synapse, 8(4), 281-8.
  63. Filloux F, Liu TH, Hsu CY, Hunt MA, Wamsley JK (1990). Selective, unilateral cortical infarction increases striatal muscarinic receptor binding: potential evidence for cortical modulation of intrastriatal cholinergic transmission. J Chem Neuroanat, 3(2), 125-32.
  64. Filloux F, Wagster MV, Folstein S, Price DL, Hedreen JC, Dawson TM, Wamsley JK (1990). Nigral dopamine type-1 receptors are reduced in Huntington's disease: a postmortem autoradiographic study using [3H]SCH 23390 and correlation with [3H]forskolin binding. Exp Neurol, 110(2), 219-27.
  65. Wamsley JK, Gehlert DR, Filloux FM, Dawson TM (1989). Comparison of the distribution of D-1 and D-2 dopamine receptors in the rat brain. J Chem Neuroanat, 2(3), 119-37.
  66. Lopez JF, Smart CR, Miller DK, Goodman GN, Ford CR, Filloux F (1989). Le Traitment de L'Obesite Morbide Par Derivation Gastrique: A Propos de 1158 Cas Operes. J Chir (Paris), 126, 5-12.
  67. Filloux F, Hunt MA, Wamsley JK (1989). Localization of the dopamine uptake complex using [3H]N-[1-(2-benzo(b)thiophenyl)cyclohexyl]piperidine ([3H]BTCP) in rat brain. Neurosci Lett, 100(1-3), 105-10.
  68. Filloux F, Dawson TM, Wamsley JK (1988). Localization of nigrostriatal dopamine receptor subtypes and adenylate cyclase. Brain Res Bull, 20(4), 447-59.
  69. Kerr LM, Filloux F, Olivera BM, Jackson H, Wamsley JK (1988). Autoradiographic localization of calcium channels with [125I]omega-conotoxin in rat brain. Eur J Pharmacol, 146(1), 181-3.
  70. Dawson VL, Dawson TM, Filloux FM, Wamsley JK (1988). Evidence for dopamine D-2 receptors on cholinergic interneurons in the rat caudate-putamen. Life Sci, 42(20), 1933-9.
  71. Filloux F, Liu TH, Hsu CY, Hunt MA, Wamsley JK (1988). Selective cortical infarction reduces [3H]sulpiride binding in rat caudate-putamen: autoradiographic evidence for presynaptic D2 receptors on corticostriate terminals. Synapse, 2(5), 521-31.
  72. Filloux FM, Wamsley JK, Dawson TM (1987). Presynaptic and postsynaptic D1 dopamine receptors in the nigrostriatal system of the rat brain: a quantitative autoradiographic study using the selective D1 antagonist [3H]SCH 23390. Brain Res, 408(1-2), 205-9.
  73. Filloux FM, Wamsley JK, Dawson TM (1987). Dopamine D-2 auto- and postsynaptic receptors in the nigrostriatal system of the rat brain: localization by quantitative autoradiography with [3H]sulpiride. Eur J Pharmacol, 138(1), 61-8.
  74. Filloux F, Thompson JA (1987). Transient chorea induced by phenytoin. J Pediatr, 110(4), 639-41.
  75. Gehlert DR, Dawson TM, Filloux FM, Sanna E, Hanbauer I, Wamsley JK (1987). Evidence that [3H]forskolin binding in the substantia nigra is intrinsic to a striatal-nigral projection: an autoradiographic study of rat brain. Neurosci Lett, 73(2), 114-8.
  76. Filloux FM, Townsend JJ (1987). Subacute leukoencephalopathy complicating acute lymphoblastic leukemia. West J Med, 146(2), 207-12.
  77. Filloux F (1986). Toxic encephalopathy caused by topically applied diphenhydramine. J Pediatr, 108(6), 1018-20.
  78. Filloux F, Townsend JJ, Leonard C (1986). Ornithine transcarbamylase deficiency: neuropathologic changes acquired in utero. J Pediatr, 108(6), 942-5.
  79. Filloux F, Kelsey DK, Bose CL, Veasy LG, Gooch WM 3rd (1985). Hydrops fetalis with supraventricular tachycardia and cytomegalovirus infection. Clin Pediatr (Phila), 24(9), 534-6.
  80. Filloux FM, Townsend JJ (1985). Congophilic angiopathy with intracerebral hemorrhage. West J Med, 143(4), 498-502.

Review

  1. Ward KE, Albensi BC, Filloux (1993). Effects of Gangliosides on Brain Edema in Hypoxicischemic Neonatal Rats. American journal of undergraduate research, 4, 21-25.
  2. Hunt ME, Narang N, Filloux F, Ertmann T, Wamsley J (1992). Characterization and Autoradiographic Localization of Binding with [3H]BTCP: A High Affinity Antagonist for the DA Uptake Complex. 7, 144, 132-135.

Book

  1. Bale, JF, Jr., Bonkowsky, JL, Filloux, F, Hedlund, GL, Larsen, PD, Morita, DM (2017). Pediatric Neurology. (Pediatric Diagnosis and Management Series).
  2. Bale, JF, Jr., Bonkowsky, JL, Filloux, F, Hedlund, GL, Nielsen, DM, Larsen, PD (2012). Pediatric Neurology: A Color Handbook.

Book Chapter

  1. Wamsley JK, Filloux (1993). In Vitro Autoradiographic Studies of Drugs Acting at Dopamine Receptor Sites. 61-79.
  2. McMahon WM, Leppert M, Filloux F, van de Wetering BJM, Hasstedt (1992). Tourette Symptoms in 161 Related Family Members. 58, 159-165.
  3. Filloux F, Dean JM, Kirsch J (1992). Monitoring the Central Nervous System. 667-697.
  4. Filloux, FM, Cipriano S Neurocutaneous Disorders.
  5. Filloux, F Movement Disorders.

Book Review

  1. Filloux F (1994). Fenichel GM. Clinical Pediatric Neurology: A Signs and Symptoms Approach. [Review of the book]. Arch Neurol, 51, 538-539.

Case Report

  1. Bonkowsky JL, Filloux F (2003). Extrapontine myelinolysis in a pediatric case of diabetic ketoacidosis and cerebral edema. Journal of child neurology, 18(2), 144-7.

Letter

  1. Filloux F, Townsend JJ (1985). Herpes Zoster Ophthalmicus with Ipsilateral Cerebellar Infarction [Letter to the editor]. Neurology, 1531.

Abstract

  1. Carey A. Wilson, Michael Spigarelli, Matt Sweney, Colin Van Orman, Fumiko Alger, Steve Merrill, Jaci Skidmore, Francis Fillou (2016). Effects of Epidiolex after 12 months in Pediatric Drug Resistant Epilepsy.
  2. Wilson CA , Spigarelli M, Sweney M, Van Orman C, Alger F, Merrill S, Skidmore J, Filloux F (October 2015). Efficacy, Adverse Effects, and Additional Benefits of Epidiolex in Children and Young Adults withTreatment Resistant Epilepsy [Abstract]. Ann Neurol, 78((suppl 19)), S180.
  3. Orrin Devinsky, Elizabeth Thiele, Linda Laux, Daniel Friedman, Anup Patel, Judith Bluvstein, Michael Chez, Charuta Joshi, Roberta Cilio, Francis Filloux, Evan Fertig, Angus Wilfong, Paul D. Lyons, Yong Park, Robert Flamini, Matthew Wong, Ian Miller, Eric Mars (2015). Efficacy and Safety of Epidiolex (Cannabidiol) in Children and Young Adults with Treatment-Resistant Epilepsy: Update from the Expanded Access Program.
  4. Orrin Devinsky, Joseph Sullivan, Daniel Friedman, Elizabeth Thiele, Eric Marsh, Linda Laux, Ian Miller, Robert Flamini, Angus Wilfong, Francis Filloux, Matthew Wong, Nicole Tilton, Patricia Bruno, Rebecca Kamens, Jane Maclean, Judith Bluvstein, Srishti Nangia, Anup Patel, Maria Roberta Cili (2015). Epidiolex (Cannabidiol) in Treatment Resistant Epilepsy.
  5. Rimer A, Filloux, F, Rogers JE, Rimer EG, Hughes AM, Kerr, LM. (October 2014). Improving Communication of Imaging Results to Families: a quality improvement project. [Abstract]. Ann Neurol, 76(S18), S184.
  6. Roundy LM, Filloux FM, Kerr L, Rimer A, Bonkowsky JL. (October 2014). Seizure Action Plans Do Not Reduce Healthcare Utilization in Pediatric Seizure Patients [Abstract]. Ann Neurol, 76(S18), S200.
  7. Nelson GR, Kerr LM, Filloux F (2014). The Effect of an Educational Intervention on Compliance with AAN Guidelines for Return Epilepsy Visits: A Quality Improvement Project.
  8. Filloux M, Lloyd MB, Goerdt A (2010). Phone Call Management in Pediatric Neurology: A Process Improvement Project [Abstract]. Ann Neurol, 68(14), 597.
  9. Candee M, Filloux F (2010). Seizure Characteristics in Pallister Killian Syndrome [Abstract]. Ann Neurol, 68(14), 130.
  10. Holsti M, Schunk J, Greenberg R, Dudley N, Adelgais K, Soprano J, Olsen C, Healy AH, Firth S, Filloux F (2009). Intranasal Midazolam versus Rectal Diazepam for the Home Treatment of Acute Seizures in Pediatric Patients with Epilepsy [Abstract]. Ann Neurol, 66(1), 597.
  11. Nelson C, Srivastava R, Filloux FM, Bonkowsky JL (2009). Inherited Leukodystrophies: Outcomes and Establishment of a Centralized Database [Abstract]. Ann Neurol, 66(1), 106-107.
  12. Rondina M, Bale JF, Petheram SJ, Enriquez R, Filloux FM, Thompson JA, Van Orman CB (2002). The Utah Stroke in Childhood Database. Presented at the WSPR Meeting. Carmel, CA, Feb [Abstract]. J Investig Med, 50, 67A.
  13. De Vivo Dc, Burke C, Trifiletti R, Filloux F, et a (1995). Glucose Transporter Protein Deficiency: An Emerging Syndrome with Therapeutic Implications. Presented at Child Neurology Soc. Meeting, San Francisco, October. 36, 491.
  14. Kurz BA, Filloux (1995). Autoradiographic Localization of Radioiodinated S-Conotoxin TXVIA Binding Sites in Rat Brain. 21,
  15. Albensi BC, Filloux FM, Rarick T, Clash KE, Schweizer M (1995). MRI of Hypoxic-Ischemic Injury in the Neonatal Rat Brain: Correlation with Histopathology. 21,
  16. Filloux FM, Schweizer MP, Rarick T, Clash KE, Albensi B (1995). Hypoxic-Ischemic Injury in the Neonatal Rat Evaluated with Magnetic Resonance Imaging. Presented at Child Neurology Soc. Meeting, Baltimore, MD, October.
  17. Albensi BC, Hendee S, Schweizer MP, Filloux (1994). 1H Imaging of Neonatal Rat Brain: In Vivo Evaluation of Hypoxia-Ischemia. 20, 180.
  18. Ward KE, McIntosh JM, Olivera BM, Filloux (1994). Transient Expression of N-Type Calcium Channels in the Forebrain of Human Infants Identified with [125I]w-Conotoxin GVIA. 20, 1686.
  19. Ramirez JM, Pierrefiche O, Schwarzacher SW, Filloux F, McIntosh JM, Olivera BM, Richter D (1994). The Influence of N-Type Calcium Channel Blockers on the Respiratory Network of Adult Cats. 20, 1755.
  20. Filloux F, McIntosh JM, Olivera BM, Ward K (1994). Ontogenetic Changes in N-Type Calcium Channels of Human Cerebellum, Hippocampus and Frontal Cortex. Presented at Child Neurology Soc. Meeting, San Francisco, October. 36, 493-494.
  21. Filloux F, Schapper A, Naisbitt SR, Olivera B, McIntosh J (1993). Postnatal Ontogeny of N-Type Calcium Channels in Rat Brain: Caudo-Rostral Evolution and Transient Expression. Presented at Child Neurology Society Meeting, Orlando, Florida, October. 34, 479.
  22. Filloux F, fitts RC, Skeen GA, White H (1993). Nitrendipine Displaces [3H]MK801 Binding Throughout Mouse Brain. 19, 719.
  23. Albensi BC, Ryujin KT, McIntosh JM, Naisbitt SR, Olivera BM, Filloux (1993). Autoradiographic Localization of [125I]w-Conotoxin GVIA Binding Sites in Human Hippocampus and Cerebellum. 19, 1755.
  24. McIntosh JM, Schapper A, Naisbitt SR, Olivera BM, Filloux (1993). N-Type Calcium Channels in Neurodevelopment - An Autoradiographic Study. 19, 1717.
  25. Filloux F, Johnson M, Gibb J, Adair J, Hanson G (1992). Striatal Neuropeptide Alterations in an Animal Model of Hypoxic-Ischemic Encephalopathy. Presented at American Academy Neurology, San Diego, CA, May 7th [Abstract]. Neurology, 42((suppl 3)), 405.
  26. Adair J, Filloux (1992). Blockade of Dopamine Type-1 (D1) Receptors Fails to Protect the Striatum From Hypoxic-Ischemic Damage in the Neonatal Rat. Presented at Child Neurology Society Meeting, New Orleans, October. 32, 463-464.
  27. Adair J, Jaeckle K, Filloux F, Fouad G, Thompson J, Tait V, Greenlee (1992). Evaluation of Acute Cerebellar Ataxia of childhood (ACAC) for Antibody Against Cerebellar Neurons. Presented at American Neurological Association Meeting, Toronto, Canada, October. 32, 234.
  28. McIntosh JM, Adams ME, Olivera BM, Filloux (1992). Calcium Channel Antagonists [125I]-w-Aga IIIA and [125I]-w-CgTx: An Autoradiographic Comparison of Binding Sites in Rat Brain. 18, 970.
  29. Filloux F, Olivera BM, McIntosh J (1992). Neomycin Displacement of [125I]-w-Conotoxin GVIA Binding is Not Uniform Across Neuroanatomical Regions: Evidence from Autoradiographic Studies. 18, 970.
  30. Hunt ME, Filloux F, Narang N, Johnson C, Wamsley J (1992). Localization and Binding Analysis of [3H]BTCP: A Dopamine Uptake Site Antagonist. 18, 996.
  31. Filloux F, Adair (1991). Differential Reduction of Dopamine Receptor Subtypes in Caudateputamen of Hypoxic-Ischemic Rat Pups. Presented at Child Neurology Society Meeting, Portland, OR, October. 30, 480.
  32. Filloux F, Townsend J (1991). Dopaminergic Neurotoxicity in Rat Striatum?. 17, 1278.
  33. Oldroyd J, Wagster MV, Folstein S, Hedreen J, Dawson T, Wamsley J, Filloux F (1990). Dopamine Uptake Sites are Increased in Huntington Disease Neostriatum. Presented at American Academy of Neurology, Miami, FL, May [Abstract]. Neurology, 40((suppl 1)), 337.
  34. Filloux (1990). Dopamine Type 1 (D1) Receptors and Adenylate Cyclase are Reduced in the Nucleus Accumbens of Micrencephalic Rats. Presented at Child Neurology Society, Atlanta, GA, October. 28, 441.
  35. Filloux (1990). Cerebrovascular Disease as a Remote Complication of Hemophilus Influenzae Meningitis. Presented at the 19th National Meeting.
  36. Filloux F, McMahon WM, Van de Wetering BMJ, Leppert (1990). Arithmomania: A Common Manifestation of Tourette Syndrome? Presented at Child Neurology Society, Atlanta, GA, October. 28, 425.
  37. Filloux F, Wagster MV, Folstein S, Hedreen J, Dawson T, Wamsley J (1989). Nigral Dopamine Type 1 Receptors are Reduced in Huntington's Disease. 15, 934.
  38. Vine D, Filloux F, Wamsley J (1989). Effects of 6-Hydroxydopamine Lesions on Dopamine Uptake Sites and on Dopaminergic and Muscarinic Receptors in the Rat Nigrostriatal System. 15, 428.
  39. Wamsley JK, Hunt M, Filloux (1988). Localization of the Dopamine Uptake Site in Rat Brain Using [3H]BTCP. 14, 1192.
  40. Kerr LM, Wamsley JK, Filloux F, Parks TN, Jackson (1987). Effects of Spider Toxins on L and N CNS Calcium Channels: Inhibition and Enhancement of Binding. 13, 102.
  41. Filloux F, Whitehouse PJ, Dawson TM, Wagster MV, Price DL, Walker LC, Wamsley J (1987). Autoradiographic Evidence for Reduction in D1 Dopamine Receptor Binding in Aged Rhesus Monkey Cortex. 13, 435.
  42. Dawson VL, Wamsley JK, Filloux FM, Dawson T (1987). Alterations in Muscarinic M-2 and Dopamine D-2 Receptors in the Rat Brain Following Intrastriatal Injection of the Cholinotoxin AF64A: An Autoradiographic Study. 13, 1198.
  43. Wamsley JK, Dawson TM, Filloux (1987). Localization of Dopamine Uptake Sites in Rat Brain Using [3H]-GBR 12395: Effects of Lesions. 13, 1113.
  44. McConnell EJ, Filloux FM, Dawson TM, Wamsley J (1987). Characterization and Localizatin of [3H]-Clozapine Binding Sites in Rat Brain. 13, 148.
  45. Filloux F, Thompson J (1985). Transient Chorea Induced by Phenytoin. Presented at Child Neurology Society Meeting, Memphis, October. 18, 412.
  46. Filloux F, Bloomer LC, Coleman L, Matsuo F, Bray PF (1984). Comparison of Evoked Potentials and Spinal Fluid Analysis in the Diagnosis of Multiple Sclerosis. Presented at American Academy of Neurology, Boston, April [Abstract]. Neurology, 34, 209.